These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29638269)

  • 1. Ajulemic acid: potential treatment for chronic inflammation.
    Burstein SH
    Pharmacol Res Perspect; 2018 Apr; 6(2):e00394. PubMed ID: 29638269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis.
    García-Martín A; Garrido-Rodríguez M; Navarrete C; Caprioglio D; Palomares B; DeMesa J; Rollland A; Appendino G; Muñoz E
    Biochem Pharmacol; 2019 May; 163():321-334. PubMed ID: 30825431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials.
    Burstein S
    AAPS J; 2005 Jun; 7(1):E143-8. PubMed ID: 16146336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
    Recht LD; Salmonsen R; Rosetti R; Jang T; Pipia G; Kubiatowski T; Karim P; Ross AH; Zurier R; Litofsky NS; Burstein S
    Biochem Pharmacol; 2001 Sep; 62(6):755-63. PubMed ID: 11551521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid.
    Parker J; Atez F; Rossetti RG; Skulas A; Patel R; Zurier RB
    Rheumatol Int; 2008 May; 28(7):631-5. PubMed ID: 18040689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.
    Gonzalez EG; Selvi E; Balistreri E; Akhmetshina A; Palumbo K; Lorenzini S; Lazzerini PE; Montilli C; Capecchi PL; Lucattelli M; Baldi C; Gianchecchi E; Galeazzi M; Pasini FL; Distler JH
    Ann Rheum Dis; 2012 Sep; 71(9):1545-51. PubMed ID: 22492781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid.
    Johnson DR; Stebulis JA; Rossetti RG; Burstein SH; Zurier RB
    J Cell Biochem; 2007 Jan; 100(1):184-90. PubMed ID: 16927387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.
    Zurier RB; Sun YP; George KL; Stebulis JA; Rossetti RG; Skulas A; Judge E; Serhan CN
    FASEB J; 2009 May; 23(5):1503-9. PubMed ID: 19124557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid.
    Liu J; Li H; Burstein SH; Zurier RB; Chen JD
    Mol Pharmacol; 2003 May; 63(5):983-92. PubMed ID: 12695526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells.
    Stebulis JA; Johnson DR; Rossetti RG; Burstein SH; Zurier RB
    Life Sci; 2008 Nov; 83(19-20):666-70. PubMed ID: 18840450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ajulemic acid: A novel cannabinoid produces analgesia without a "high".
    Burstein SH; Karst M; Schneider U; Zurier RB
    Life Sci; 2004 Aug; 75(12):1513-22. PubMed ID: 15240185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.
    Tepper MA; Zurier RB; Burstein SH
    Bioorg Med Chem; 2014 Jul; 22(13):3245-51. PubMed ID: 24856183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid.
    Zurier RB; Rossetti RG; Burstein SH; Bidinger B
    Biochem Pharmacol; 2003 Feb; 65(4):649-55. PubMed ID: 12566094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma.
    Ambrosio ALB; Dias SMG; Polikarpov I; Zurier RB; Burstein SH; Garratt RC
    J Biol Chem; 2007 Jun; 282(25):18625-18633. PubMed ID: 17462987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells.
    George KL; Saltman LH; Stein GS; Lian JB; Zurier RB
    J Cell Physiol; 2008 Mar; 214(3):714-20. PubMed ID: 17786950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabimimetic properties of ajulemic acid.
    Vann RE; Cook CD; Martin BR; Wiley JL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):678-86. PubMed ID: 17105826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain measurements and side effect profile of the novel cannabinoid ajulemic acid.
    Salim K; Schneider U; Burstein S; Hoy L; Karst M
    Neuropharmacology; 2005 Jun; 48(8):1164-71. PubMed ID: 15910892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of ajulemic acid and its glucuronide in human plasma by gas chromatography-mass spectrometry.
    Batista C; Berisha M; Karst M; Salim K; Schneider U; Brenneisen R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):77-82. PubMed ID: 15866495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids, endocannabinoids, and related analogs in inflammation.
    Burstein SH; Zurier RB
    AAPS J; 2009 Mar; 11(1):109-19. PubMed ID: 19199042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.